Immunic reported $38.36M in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Alterity Therapeutics Limited AUD 1.73M 2.77M Dec/2025
BioMarin Pharmaceutical USD 1.6B 59.17M Sep/2026
Cipla INR 69.77B 366.6M Sep/2026
Clal Biotechnology ILS 6.66M 3.75M Dec/2023
Compugen USD 22.63M 596K Jun/2026
CSL USD 4.61B 207M Dec/2025
Enanta Pharmaceuticals USD 44.73M 3.83M Dec/2025
Grifols EUR 2.37B 156.97M Dec/2025
Immunic USD 38.36M 7.74M Mar/2026
Insmed USD 596.57M 157.83M Sep/2026
Omeros USD 85.5M 2.28M Jun/2025
OraSure Technologies USD 25.12M 18.96M Jun/2026
Quidel USD 1.07B 73.7M Sep/2026
Ultragenyx Pharmaceutical USD 389M 38M Sep/2026
United Therapeutics USD 624.3M 16.5M Sep/2026